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Abstract Exercise as a key prevention strategy for dia-
betes and obesity is commonly accepted and recommended
throughout the world. Unfortunately, not all individuals
profit to the same extent, some exhibit exercise resistance.
This phenomenon of non-response to exercise is found for
several endpoints, including glucose tolerance and insulin
sensitivity. Since these non-responders are of notable quan-
tity, there is the need to understand the underlying mecha-
nisms and to identify predictors of response. This displays
the basis to develop personalized training intervention
regimes. In this review, we summarize the current knowl-
edge on response variability, with focus on human studies
and improvement of glucose homeostasis as outcome.
Keywords Non-response  Adverse response to exercise 
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Introduction
The global epidemic of type 2 diabetes burdens humankind.
TheWHOprojects that diabetes will be the 7th leading cause
of death in 2030. For prevention, healthy diet as well as
achievement and maintenance of normal body weight are
recommended. Furthermore, at least 30 min of regular,
moderate-intense physical activity five times a week is
required [1, 2]. Nevertheless, our strategies to prevent type 2
diabetes are still insufficient; since decades, a major purpose
of research is to develop reasonable prevention strategies and
to specify detailed pathomechanisms leading to diabetes.
There are myriads of intervention studies dealing with the
best exercise type, frequency, intensity, and duration, further
sophisticated by additional diets [3–20 and many more], and
the scientific discussion is still ongoing. Indeed, positive
effects of regularly performed exercise on cardiorespiratory
fitness and metabolic control are without dispute. In most of
the well-known diabetes prevention studies as DPS, DDP,
HERITAGE, LookAHEAD, STRRIDE, Da Qing Diabetes
Study, TULIP, and others, the risk reduction for diabetes, the
metabolic syndrome or cardiovascular events ranges around
35 % [4, 21–35]. Despite this knowledge, less than 40 % of
European countries developed national recommendations
for physical activity [36].
Response variability
Most of the conducted studies found not only improvements
in metabolic and cardiorespiratory endpoints after training
intervention, but also highly variable inter-individual
responses [37–39]. Maximum oxygen uptake (VO2max) is
the standard parameter of cardiorespiratory fitness and is
widely used to document the effectiveness of training. The
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HERITAGE trial identified low responders and high
responders for improvements of VO2max [40]. A similar
variability for glucose homeostasis, reflected by insulin
sensitivity, acute insulin response, glucose effectiveness,
and glucose disappearance index was shown [41]. The gen-
eral distribution of individual changes seems to have a two-
sided shape, ranging from high responders to even adverse
responders that show a deterioration of the respective end-
point. Notably, the term ‘‘non-response to exercise’’ always
needs a clear association with a specific endpoint. It is used
with respect to changes in several, different parameters
assessed before and after training, e.g., fitness, cardiovas-
cular events, muscle mass, metabolic risk profiles, lipid
metabolism, insulin resistance, glucose tolerance, and oth-
ers. In this review, we focus on the failure to improve whole-
body glucose homeostasis after training interventions in
humans. Physical activity is often included in lifestyle
intervention programs combining dietary regimes with
exercise, and sometimes we also refer to data based on
lifestyle intervention. Since it is not possible to differentiate
between exercise-dependent and exercise-independent
effects in these studies, this is always clearly stated.
What about the quantity of these non-, low-, or even
adverse responders? As recently reviewed [42], the number
of adverse responders with respect to fasting insulin
including six exercise training studies (HERITAGE,
DREW, INFLAME, STRRIDE, MARYLAND, and
JYVASKYLA) averaged 8.3 %. Non-response defined as
no improvement regarding glucose homeostasis, leads to
7–63 % non-responders [41, 43–49]. For further details,
see Table 1. Most of the conducted studies are performed
without a control group. Thus, the opinion exists that
exercise might cause adverse metabolic effects for some
individuals. However, a study performed with 87 partici-
pants including a control group [45], demonstrated clearly
a decreased number of an adverse response (41 %) versus
76 % in control group; the adverse response was defined as
increased fasting glucose, 2-h glucose, and triglycerides, as
well as a decrease for HDL-cholesterol.
Notably, the failure to improve onemetabolic factor is not
necessarily reflected by a non-response in other variables,
e.g., VO2max, and vice versa [50]. Although there is a clear
positive correlation of VO2max and insulin sensitivity in the
general population [51–53] and an increase in VO2max
correlates with the improvement in glucose homeostasis [54]
and insulin sensitivity [55] in large lifestyle intervention
programs, this is not true for each individual. In 202 diabetic
individuals of the HART-D study, only 37 % had a marked
increase in VO2max, but all profited regarding metabolic
parameters, irrespective of VO2max response [56]. Fur-
thermore, metabolic fitness parameters like respiratory
exchange ratio, maximal heart rate, and maximal ventilatory
equivalent do not relate to changes in aerobic capacity [57].
Thus, despite a relevant exercise-related improvement
of systolic blood pressure, body weight, VO2max, lipid
profile, etc., one may not have a beneficial effect on
Table 1 Quantity of non-responders
Citation Population Intervention Duration Outcome Non-responders
(%)a
Boule´ [41] n = 596, healthy Endurance training, 39/week,
55–75 % VO2max,
20 weeks Insulin sensitivity 42





-500 kcal per day,
pedometer use
12 months Glucose tolerance status 62.5
Hagberg [49] n = 110, healthy endurance training, 39/week,
50–70 % VO2max
26 weeks Insulin sensitivity 25
Yates [45] n = 29, prediabetic education program with
pedometer use
12 months 2-h glucose 7b
Winett [44] n = 159, prediabetic Resistance training, 2 9/week 3 months 2-h OGTT 44c
Stephens [48] n = 42, diabetic Aerobic, resistance training, or
combination thereof
9 months Combination of




Osler [47] n = 14, prediabetic Nordic walking, 5 h/week,
unsupervised
20 weeks Glucose tolerance status 36
Quantity of non-responders with respect to glucose homeostasis
a Meaning no improvement, unless stated otherwise
b Adverse response
c Estimated from graph
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glucose homeostasis; this adds even more complexity to
this issue.
It is still under debate [11, 16, 42, 43, 58–62], which
training intervention is the best, and this will not be in
focus of this review. However, a recent study gave hint for
a combination of low-amount/vigorous-intensity aerobic
exercise and resistance training being favored [63]. High-
intensity interval training has been practiced by athletes for
some time [64]; recently it receives much interest as
promising part of lifestyle intervention programs [65]. It
can be superior to moderate-intense, time-consuming
continuous training in improving cardiorespiratory fitness
[66], and beneficial effects on glucose homeostasis or
insulin sensitivity have been shown after just short training
duration [67, 68]. If high-intensity interval training will be
advantageous, and which subpopulation is suitable to that,
we will learn from future randomized, controlled studies.
Additionally, the question arises, if the highly individual
responses to exercise might be overcome by different
training regimes.
To sum up, individual exercise response is known for
several years now [11, 37, 57, 69, 70], but shifting the
focus on non-response in terms of glucose homeostasis is
just beginning [29, 43, 46–48, 56, 71, 72].
Prediction of and mechanisms for failure
Understanding and defining the individual susceptibility for
non-response will be a major purpose in the future. This is
the basis for the development of personalized training
strategies to prevent and treat type 2 diabetes. Regarding
success-predictive baseline values, our knowledge is lim-
ited to few studies and endpoints, as reviewed by [73], and
the results are partly complementary. Of course, personal
adherence to lifestyle intervention is a major fundament for
success [74]; thus, exercise studies should exclusively be
supervised.
Beyond this, in the HERITAGE study, baseline values
were found to account for *40 % variability in training-
related changes; but only for some traits, such as sub-
maximal heart rate and blood pressure, where high baseline
levels were associated with major exercise-driven
improvements [37]; but not for baseline VO2max, HDL,
age, nor for sex and race [39], where no relationships were
found; contrarily, age was mentioned as a relevant variable
in dose-responsiveness to exercise [75], as older adults
might require higher doses of training. Another study
showed, that there are no non-responders in elderly prac-
ticing a prolonged resistance training [60]. Notably, insulin
sensitivity or glucose tolerance was not among the end-
points of this study [60]. Additionally, women with low
fitness at baseline were shown to have greater exercise-
related fitness improvements [76].
For glucose homeostasis, there are quite little data. Risk
factors for non-response are speculated, but far from being
comprehensively understood. But recognizing these indi-
viduals that fail to profit from exercise is of major impor-
tance. In a 9 months exercise study, long duration of type 2
diabetes and increases in serum free fatty acids (FFA) were
positively associated with HbA1c changes, whereas serum
adiponectin levels and muscle protein content of peroxi-
some proliferator-activated receptor c coactivator 1a
(PGC1a) correlated inversely with changes in HbA1c [77].
In plasma, reduction of ceramides was correlated with
exercise-related improvements in insulin sensitivity [78]. A
whole blood gene expression analysis after 12 weeks of
lifestyle intervention in Latino adolescents showed up-
regulated genes, e.g., for insulin signaling, glucose uptake,
and glycogen storage as well as down-regulation of genes
involved in inflammatory pathways, and the analysis
exhibited five times the number of regulated transcripts in
insulin sensitivity- responders compared to non-responders
in terms of insulin sensitivity [79]. This might point to a
reduced adaption to training stress in non-responders. From
the Diabetes Prevention Program, we know that low insulin
secretion and low insulin sensitivity at baseline generally
predict higher diabetes risk regardless of the treatment
regime [80]. Our own data from the TULIP study showed
low insulin secretion and sensitivity, low cardiorespiratory
fitness, high liver and visceral fat, as well as high fetuin A
predictive for non-response regarding glucose homeostasis
[55, 72, 81, 82], whereas age, sex, and BMI at baseline
were not predictive. Notably, this was a lifestyle inter-
vention study, and conclusions on exercise-specific chan-
ges can only be speculated. Indeed, exercise-driven
improvement of glucose tolerance was only shown in
insulin-resistant individuals with adequate insulin secretion
[83].
Thus, there are several pathomechanisms conceivable
leading to failed exercise-related improvement of glucose
homeostasis: most expectedly, no improvement in insulin
sensitivity with consequences in all insulin-responsive tis-
sues (muscle, adipose tissue, liver, brain) leads to less
glucose deposition and increased endogenous glucose
production; furthermore, less insulin secretion or altered
glucose/fatty acid metabolism could be pathogenic. Pre-
sumably, the non-response regarding glucose homeostasis
might be a combination of these factors, and distinguishing
this will be very sophisticated.
Is worse glucose homeostasis per se objectively a risk
factor for non-response? There is some evidence given by
several exercises [45, 84–86] and lifestyle intervention
studies [29, 46, 87] that individuals with higher metabolic
burden seem to profit more. Contrarily, in another study,
responders in terms of glucose tolerance had better glucose
homeostasis values at the beginning than non-responders
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[47]; additionally, women at lower genetic risk for obesity
(calculated by a risk score dependent on 21 SNPs associ-
ated with BMI variation) showed more favorable responses
regarding resistance training-associated changes of body
fat composition [88]. These partly conflicting results might
be explained by a ceiling-effect for some variables, dif-
ferent populations and study settings. Alternatively, there
might be a threshold in any metabolic parameter—perhaps
insulin secretion?—beyond which the benefit suddenly
converts to the opposite. Until now, there is too much
speculation on pathomechanisms and we clearly require
further studies in well-defined populations under controlled
conditions for better characterization of responders and
non-responders.
Genetic aspects of non-response
Already in the 1980s, the relevance of heredity in exercise-
induced adaptations was shown [89]. For exercise-related
improvements of VO2max, the heritability is reported to be
about 47 % [40, 90]. Single nucleotide polymorphisms
(SNPs) are found to play a role in the training-induced
changes in VO2max [91]; also for the endpoint muscle
strength this was shown [92]. A combination of several
SNPs contributes to *50 % of the inter-individual vari-
ance in changes of VO2max [93, 94], pointing to a multi-
factorial inheritance of general non-response. A genetic
variant in NDUFB6, encoding for complex I of the respi-
ratory chain, can modify the individual response of the
ATP synthase flux, even independently from exercise-re-
lated improvements of insulin sensitivity [95]. For meta-
bolic syndrome in general, risk allele carriers of IL6R had
more profit from a lifestyle modification including diet and
exercise [96]. In genome-wide linkage-scans, a genomic
region close to the leptin locus emerged to contribute to the
fasting insulin response to exercise training [97]. And in
180 Brazilians, an FTO polymorphism was associated with
decreased fasting plasma glucose after 9-month lifestyle
intervention [98]. Additionally, polymorphisms in ADI-
POR1 [99], PPARG [49], PPARD [100], PPARGC1A
(encoding PGC1a) [101], TCF7L2 [102], and SIRT1 [103]
were shown to impact the glucose homeostasis response to
lifestyle intervention [71].
Exercise also regulates epigenetic modifications [104],
in CpG-islands [105], enhancer sites [106, 107], as well as
on histones [108]; furthermore, micro-RNA expression
changes due to exercise were shown, in plasma [109] and
skeletal muscle [110]. There is evidence that different
doses of exercise reveal different inflammatory miRNA
responses [111]. Notably, insulin sensitivity might influ-
ence the epigenetic response to exercise [112]. But inves-
tigating the relevance of differences in epigenetic
regulation for the variability in exercise response has just
started. One study reported highly variable responses in
muscle mass upon resistance training and deciphers dif-
ferentially expressed microRNAs [113].
Impact and interplay of genetic factors for non-response
will be specified in the future. Additionally, whether the
genetic influence might be overcome by higher training
intensities/volumes/types is not clear yet and requires
future research.
Muscle
Skeletal muscle displays one of the most important target
tissues of insulin. It accounts for more than 85 % of
insulin-dependent glucose uptake [114]; thus, mechanistic
studies to elucidate the metabolic adaptation to exercise
and its regulation mostly focus on skeletal muscle. The
training-induced improvement in glucose disposal has been
attributed among other non-muscle adaptations to increases
in muscle mass, muscle fiber type switching, mitochondrial
biogenesis, and enhanced capillarization [115–117]. On a
molecular level, increased abundance and altered post-
translational modifications of proteins important in uptake
and oxidation of glucose and fatty acids have been shown
[118–121]. Together, enhanced fuel oxidation in muscle
appears to be one major key mechanism of improved
glucose control after training [24].
Given the relevance of oxidative metabolism in the
prevention of poor glucose homeostasis, it was speculated
that differences in mitochondrial content and mitochondrial
fuel oxidation in response to training might play a role in
exercise non-response [43]. In a subgroup of the HART-D
study, non-responders were defined as diabetic individuals
with constant HbA1c, percent body fat, and BMI, and
reduced muscle mitochondria content after exercise [48]. A
microarray analysis of muscle biopsies of these non-re-
sponders at baseline revealed 186 differentially regulated
mRNAs compared with responders, mostly affecting sub-
strate metabolism and mitochondrial biogenesis/function
[48]. Increased mRNA levels of genes encoding for mito-
chondrial proteins were also found in prediabetic respon-
ders versus non-responders in terms of glucose tolerance
[47]. Higher muscle concentrations of the tricarboxylic
acid cycle intermediates were found to correlate best with
exercised-induced change in insulin sensitivity [63], at
least in a vigorous-intensity exercise group. In 66 untrained
participants of a resistance training intervention, a proin-
flammatory transcript profile was associated with the fail-
ure to induce muscle hypertrophy, whereas genes involved
in muscle development were uniquely expressed in
responders regarding myofiber hypertrophy at baseline
[122].
To conclude, the data on specific adaptations in the
muscle of responders and non-responders highlight the
Endocrine (2016) 51:390–401 393
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relevance of mitochondrial pathways for the improvement
of metabolic control, independent of different biopsy tim-
ings, training regimes, heterogeneous cohorts, and different
definitions of metabolic non-response among studies.
Notably, for detailed pathomechanisms, we have to dif-
ferentiate thoroughly between mitochondrial content,
OXPHOS capacity, and fat oxidation. An important issue
here is to understand the individual variability in these
mitochondrial adaptations and the molecular basis for the
susceptibility to resist to training intervention.
Adipose tissue
Adipose tissue contributes relevantly to whole-body
metabolism, both as metabolic sink and an endocrine organ
[123, 124]. Notably, being obese implies a greater risk for
development of type 2 diabetes than being inactive [125].
Improvement of glucose homeostasis after 1 year of com-
bined lifestyle intervention in 104 viscerally obese men
was not independently associated with improvement of
cardiorespiratory fitness, but with changes in visceral and
subcutaneous adipose tissue [46]. Thus, beneficial meta-
bolic improvements seem to be mediated by adipose tissue
[46, 72, 126, 127]. That is in line with an observation that
there are no weight-independent exercise effects on
adipokines [128]. Recent studies in mice affirmed a role for
subcutaneous adipose tissue in exercise-induced improve-
ments in glucose homeostasis [129, 130]. On the other
hand, anti-inflammatory effects of exercise on adipose
tissue are reported to be weight-loss-independent [131].
Effects of exercise affect all fat compartments. General
exercise-related changes on adipose tissue comprise fat
loss per se, beneficial shifts in body fat composition,
altered mitochondrial function, and secretory responses
[125, 131–134]. It seems to be established that exercise
leads to increased subcutaneous adiponectin mRNA levels,
while other adipokines and their systemic relevance are
under discussion [132]. In a 6-month supervised exercise
intervention in 47 healthy sedentary men [135], genes
encoding the respiratory chain, histone subunits, small
nucleolar RNAs, ribosomal proteins, and pathways like
oxidative phosphorylation were up-regulated, whereas Wnt
and mitogen-activated protein kinase (MAPK) signaling
pathways were down-regulated due to exercise.
Elevated adipose tissue peroxisome proliferator-acti-
vated receptor gamma (PPARg) and PGC1a were early
supposed to mediate the beneficial effects of exercise on
insulin sensitivity [136]. Also suppressed angiogenesis in
white adipose tissue after exercise was associated with
insulin resistance [137]. Additionally, endothelial nitric
oxide synthase (eNOS) seems to be a major control point in
the fragile energy metabolism balance [133], as it gained
attention as an inductor of mitochondrial biogenesis [138].
Conversion of white adipocytes to more energy-dissi-
pating brown-like adipocytes is known as browning. This
effect might also play a role in adipocytes’ response to
exercise [139]. There is further evidence that high physical
activity leads to increased brown adipose tissue activity
[140]. If browning in humans is of relevant impact, is
currently under discussion [141–143]. In this respect, the
role of a PGC-1a-dependent exercise-induced myokine and
browning factor identified in mice [144], named irisin, was
recently very controversially discussed in humans [145–
148].
In conclusion, there is good evidence that not only
muscle, but also altered adipose tissue metabolism can
contribute to non-response.
Liver
Long-term lifestyle intervention leads to the reduction of
intrahepatic lipids [29, 72, 149–151]; this reduction in liver
fat mediates a relevant part of the beneficial effects on
insulin resistance, more than reduction of other fat com-
partments does [72]. Furthermore, we and others have
shown that liver fat is the most reactive fat compartment in
response to a lifestyle intervention [72, 152]. Notably, after
2 h of aerobic exercise, intrahepatic lipids in 18 healthy
lean volunteers increased about 35 % from baseline,
pointing to intrahepatic lipids as a very flexible fuel store
[153] serving as a buffer for excess free fatty acids. Data on
molecular alterations in the liver upon exercise are very
limited, but exercise studies in mice gave hint for a pro-
nounced regulation of signal transduction and gene
expression in the liver [154, 155]. Recent data obtained
from liver vein samples verified the hepatic release of
FGF21 during exercise in humans [156]. This exercise-
dependent regulation of FGF21, a liver-derived factor with
possibly beneficial effects on glucose control and body
weight regulation [157], opens a further perspective for the
individual regulation of exercise response on the level of
hepatokines.
Brain
Exercise enhances functional brain capabilities [158].
Furthermore, exercise was shown to improve whole-body
metabolism via the regulation of central control mecha-
nisms: reduced appetite and food intake were reported
[159, 160].
Vice versa, high-cerebral insulin sensitivity in humans
at baseline was associated with higher loss of body fat
during lifestyle intervention [161]. Unfortunately, the
cohort was too small to find direct effects on glucose
homeostasis, independent of fat loss. Since cerebral insulin
sensitivity was found to affect peripheral insulin sensitivity
394 Endocrine (2016) 51:390–401
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[162, 163] and other brain functions as reviewed in [164], it
is conceivable that individual differences of central insulin
action are relevant for the response variability to exercise
on glucose homeostasis. For further understanding of the
exercise-brain-metabolism axis, we will need more human
studies.
Inflammation
A role of subclinical inflammation in the development of
obesity and diabetes is widely accepted. This linkage
between inflammation and diabetes was extensively shown
in various organs, like adipose tissue [165], skeletal muscle
[166], and liver [167]. As the issue is very complex, and
most of the molecules have both pro- and anti-inflamma-
tory effects, the relevance of exercise-regulated cytokines
and chemokines for the prevention or treatment of meta-
bolic diseases is still under debate. Exercise-induced ben-
eficial effects on metabolic control have been linked to
several cytokines and chemokines with known functions in
inflammatory processes [166]. Additionally, anti-inflam-
matory influences of regular exercise have been shown in
several studies [168, 169]. In brain, anti-inflammatory
exercise effects were reported, at least in mice [170]. Thus,
although exercise acutely can induce inflammatory pro-
cesses, predominantly after an unadjusted work load and
eccentric exercise [171], it can help to reduce subclinical
inflammation in the long run.
For exercise non-response, a role of a differential reg-
ulation of pro-/and anti-inflammatory cytokines can only
be speculated; recently, this was supposed for skeletal
muscle [122].
Conclusion
In this review, we discussed individual responses to exer-
cise training in terms of glucose homeostasis; current ideas
for underlying pathomechanisms for the lack of improve-
ment in humans were summarized, as illustrated in Fig. 1.
In general, we should clearly encourage our patients to
increase their physical activity. There are many aspects,
e.g., socio-economic, quality of life etc., beyond specific
metabolic endpoints, which are worth being an active
individual. Nevertheless, personalized adjustments of
exercise recommendations are inevitable, different training
strategies for individual subgroups may be necessary.
Despite the very complex issue (different endpoints,
training types, nutrition, populations, highly individual
participants, etc.), we hopefully will promote our knowl-
edge to tackle the non-response. Therefore, we do need
further studies to unravel detailed mechanisms for insuffi-
cient responses to exercise training. Thus, well-designed,
supervised studies with an adequate number of participants
and clearly defined conditions for non-response are
demanded; for elucidation of non-responders’ characteris-
tics and possible pathomechanisms, we should perform
pure training interventions in deeply phenotyped cohorts;
without noise of additional diet interventions, that should
be investigated separately. Novel studies should address
the following questions: Who is the non-responder? What
are risk factors for non-response? How can we predict the
non-response with easy-to-use parameters? Which of sev-
eral training regimes could overcome non-response? Is
interval training the new winner? Is there a correlation of
several metabolic endpoints? To what extent? And valid
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Fig. 1 Hypothetical and
observed contribution to
exercise non-response with
respect to glucose homeostasis.
For details, see text
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for every individual? What are the underlying molecular
pathomechanisms for non-response? Are we able to dis-
criminate discrete pathomechanisms, and what is their
impact on whole-body glucose homeostasis?
More detailed, we need exact tissue-specific (using the
biopsy technique) measurements, e.g., of mitochondrial
content and function, and need to clarify a possible
pathogenic role for inflammation. By omics-technology,
we could drive new hypotheses, determining further
mechanistic studies. Subsequently, this will hopefully
generate novel ideas for a potential pharmacological
treatment of non-response. Furthermore, with the modern
technique of brain imaging available, we should specify the
central-nervous influence on exercise non-response. It is
mandatory to design supervised studies. There are myriads
of large intervention studies showing benefits of exercise;
thus, we should concentrate our efforts and funds on the
above-mentioned questions. Last but not least, all our
results should be feasible for our patients’ daily routine far
away from a controlled supervised study setting.
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